Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTA1 | P08263 | 6/20 | 0.45 |
| ▸ | GSTP1 | P09211 | 6/20 | 0.45 |
| ▸ | CD69 | Q07108 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.40 |
| ▸ | PTPRC | P08575 | 4/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.40 |
| ▸ | PTPRB | P23467 | 4/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5574627 | 0.99 | GSTA1 (0.44) | GSTA1GSTP1CD69PTPN1PTPRC | |
| SCHEMBL5572030 | 0.88 | MAP4K4 (0.39) | GSTA1GSTP1CD69LGALS1KDM4E | |
| SCHEMBL5574629 | 0.82 | ALDH1A1 (0.47) | GSTA1GSTP1CD69KDM4EMEN1 | |
| SCHEMBL711720 | 0.72 | CD69 (0.55) | GSTA1GSTP1CD69PTPN1PTPRC | |
| SCHEMBL5574576 | 0.69 | CD69 (0.56) | GSTA1GSTP1CD69 | |
| SCHEMBL5570772 | 0.68 | CD69 (0.48) | GSTA1GSTP1CD69PTPN1PTPRC | |
| SCHEMBL217079 | 0.68 | CYP3A4 (0.56) | KDM4EMEN1ALDH1A1KMT2A | |
| SCHEMBL8368429 | 0.68 | CD69 (0.47) | GSTA1GSTP1CD69PTPN1PTPRC | |
| SCHEMBL18538266 | 0.68 | CD69 (0.40) | GSTA1GSTP1CD69PTPN1PTPRC | |
| SCHEMBL18538281 | 0.68 | CD69 (0.40) | GSTA1GSTP1CD69PTPN1PTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070027075-A1 | Compositions and methods for targeted drug delivery | UNIVERSITY OF CINCINNATI | 2007-02-01 | — | — | US | disclosed |
| WO-2005004795-A2 | COMPOSITIONS AND METHODS FOR TARGETED DRUG DELIVERY | UNIVERSITY OF CINCINNATI (US) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027075-A1 | Compositions and methods for targeted drug delivery | SLC47A1, SLC47A2, SLC46A1 | GSTA1 1928/4885GSTP1 2654/4885CD69 2441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.